Knowledge Hub
Categories:
- Allergy [1]
- Antimicrobials & infection [5]
- Autoimmune [1]
- Chemical Pathology [15]
- Endocrinology [1]
- Epidemiology [3]
- Gastrointestinal [2]
- Genetics [6]
- Genitourinary [2]
- Haematology [9]
- HIV/TB [3]
- Infectious Diseases [10]
- Neurology [4]
- Obstetric and Neonatal care [4]
- Oncology [1]
- Ophthalmology [1]
- Respiratory [2]
- Serology [3]
- Virology [44]
With regard to Designated Service Provider (DSP) Contracts the following law is pertinent for service providers who are not a DSP:
- In terms of Section 59 (2) of the Medical Schemes Act 131 of 1998 the medical scheme must pay valid invoices within 30 days of receipt thereof or advise both the member and service provider of reasons why the invoice is not valid and provide the opportunity to correct the invoice.
- Where services are in respect of medical emergencies or involuntarily obtained services for PMB conditions, the scheme has to pay for the full cost of the services provided without deduction or co-payment or limiting the tariff amount. (Regulation 8 (1) of the Medical Schemes Act no. 131 of 1998.)
- DOH notice 214 of 2021 requires that a scheme pays for services provided at the same rate and in terms of the same rules as they pay their DSPs in respect of services voluntarily obtained, whether they are PMBs or not.
- The process followed in respect of appointing a DSP is required to be fair, equitable, transparent, competitive or cost effective as required in terms of Notice 214 of the DOH.
In summary:
- The law protects the patient’s choice to use their laboratory of choice, even if it is not a DSP, and the scheme is still obliged to reimburse us at the scheme rate for valid claims.
- This is true for PMB conditions as well as non-PMB conditions.
- The medical scheme must pay valid invoices within 30 days or advise both the member and service provider of reasons why the invoice is not valid and provide the opportunity to correct invoice.
- A scheme must pay for the services provided at a tariff not less than what they would pay a DSP.
- Should any patient have a valid claim rejected because we are not a DSP, we can assist.
PLATELET FUNCTIONS
The use of the Platelet Analyser (PFA-200) in the investigation of platelet disorders. Global platelet function tests are useful in the investigation of individuals with a pathological bleeding tendency or who are on anti-platelet therapy. As global tests...
New Meningitis / Encephalitis PCR test
PathCare is introducing a new Meningitis/Encephalitis Multiplexed PCR test with an expanded organism profile and reduced turn-around time. This new PCR test is able to detect 14 potential central nervous system (CNS) pathogens will replace the current...
CYSTIC FIBROSIS (CF) TESTING UPDATE
CYSTIC FIBROSIS (CF) TESTING UPDATE The diagnosis of CF is made in individuals with one or more clinical features of CF who have either an elevated sweat chloride concentration on two or more occasions or have CF-causing mutations in the CFTR...
Bacterial Meningitis Multiplex PCR
Bacterial Meningitis Multiplex PCR PathCare is introducing a multiplex PCR test for the detection of the 5 most common bacterial causes of meningitis in cerebrospinal fluid (CSF): Streptococcus pneumoniae, Haemophilus influenzae type b,...
Rhino & Enteroviruses
Rhino & Enteroviruses The genetic similarities between rhinoviruses and enteroviruses may lead to cross amplification in molecular assays.Apositive outcome for these targetsonthe current multiplex assay (BioFire) in use in our laboratorymay...
Respiratory Tract Infection
Respiratory Tract Infections The causes of respiratory tract infection (RTI) are diverse and may be bacterial, viral or fungal in nature, or a combination of these. To assist with the identification of the causative agents of respiratory tract...
Influenza
Influenza begins suddenly and may include the following symptoms: fever, cough, sore throat, runny nose, body aches, headaches, chills, fatigue and sometimes diarrhoea and vomiting. These symptoms do not always mean that…
Thyroid Function Test Changes
This downloadable pdf provides an overview of changes on PathCare reference ranges for Thyroid function tests. Thyroid Function Test Change
The Urine TB LAM Assay
Key global priorities for tuberculosis (TB) care and control include improving case detection and detecting cases earlier. Read more about the Urine TB LAM Assay test in this downloadable pdf. The Urine TB LAM Assay